by Fou | 2022-01-28 | Publikationer
Predicted vs. observed radiographic progression in early rheumatoid arthritis (POPeRA): results from a randomized trial. Levitsky A, Forslind K, van Vollenhoven RF; SWEFOT trial group. Scand J Rheumatol. 2015;44(5):348-53.
by Fou | 2022-01-28 | Publikationer
Comparing Five Year Out-Come in Two Cohorts of Patients with Early Rheumatoid Arthritis – A BARFOT Study. Andersson ML, Forslind K, Hafström I. Open Rheumatol J. 2015 Feb 3;9:8-15.
by Fou | 2022-01-27 | Publikationer
Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial. Hambardzumyan K, Bolce RJ, Saevarsdottir S, Forslind K, Wallman JK, Cruickshank SE, Sasso EH, Chernoff...
by Fou | 2022-01-27 | Publikationer
A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission. Chatzidionysiou K, Turesson C, Teleman A, Knight A, Lindqvist E, Larsson...
by Fou | 2022-01-27 | Publikationer
MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis. Forslind K, Svensson B. Scand J Rheumatol. 2016;45(2):99-102.
